S&P 500
(0.37%) 5 118.97 points
Dow Jones
(0.29%) 38 351 points
Nasdaq
(0.39%) 15 990 points
Oil
(-1.10%) $82.93
Gas
(3.48%) $1.990
Gold
(-0.01%) $2 347.00
Silver
(0.04%) $27.55
Platinum
(3.19%) $951.55
USD/EUR
(-0.03%) $0.934
USD/NOK
(-0.05%) $11.02
USD/GBP
(-0.28%) $0.798
USD/RUB
(1.84%) $93.56

Realaus laiko atnaujinimai Bausch Health Companies [BHC]

Birža: NYSE Sektorius: Healthcare Pramonė: Drug Manufacturers - Specialty & Generic
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-02)

Expected move: +/- 11.09%

Atnaujinta29 bal. 2024 @ 17:31

1.56% $ 8.85

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 17:31):

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology...

Stats
Šios dienos apimtis 163 755
Vidutinė apimtis 2.85M
Rinkos kapitalizacija 3.23B
EPS $0 ( 2024-02-22 )
Kita pelno data ( $0.740 ) 2024-05-02
Last Dividend $1.000 ( 2010-11-10 )
Next Dividend $0 ( N/A )
P/E -5.46
ATR14 $0.0130 (0.15%)
Insider Trading
Date Person Action Amount type
2024-03-29 Paulson John Buy 5 890 Common Shares, No Par Value
2024-03-29 Icahn Brett Buy 3 122 Common Shares, No Par Value
2024-03-29 Robertson Russel C Buy 2 945 Common Shares, No Par Value
2024-03-29 Wechsler Amy B Buy 647 Common Shares, No Par Value
2024-02-29 Barresi John S Buy 39 126 Common Shares, No Par Value
INSIDER POWER
67.94
Last 100 transactions
Buy: 2 132 507 | Sell: 336 154

Tūris Koreliacija

Ilgas: -0.28 (neutral)
Trumpas: -0.56 (weak negative)
Signal:(62.551) Neutral

Bausch Health Companies Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
YSAC0.851
PKE0.81
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Bausch Health Companies Koreliacija - Valiuta/Žaliavos

The country flag -0.01
( neutral )
The country flag -0.33
( neutral )
The country flag 0.00
( neutral )
The country flag -0.25
( neutral )
The country flag 0.53
( weak )
The country flag 0.02
( neutral )

Bausch Health Companies Finansinės ataskaitos

Annual 2023
Pajamos: $8.76B
Bruto pelnas: $6.20B (70.78 %)
EPS: $-1.620
FY 2023
Pajamos: $8.76B
Bruto pelnas: $6.20B (70.78 %)
EPS: $-1.620
FY 2022
Pajamos: $8.12B
Bruto pelnas: $5.76B (70.90 %)
EPS: $-0.590
FY 2021
Pajamos: $8.43B
Bruto pelnas: $6.04B (71.61 %)
EPS: $-2.67

Financial Reports:

No articles found.

Bausch Health Companies Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Bausch Health Companies Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 6.11 - average (70.51%) | Divividend Growth Potential Score: 2.84 - No dividend growth expected in the near future
Information
First Dividend $0.500 2005-11-28
Last Dividend $1.000 2010-11-10
Next Dividend $0 N/A
Payout Date 2010-12-22
Next Payout Date N/A
# dividends 22 --
Total Paid Out $6.43 --
Avg. Dividend % Per Year 0.00% --
Score 3.06 --
Div. Sustainability Score 6.11
Div.Growth Potential Score 2.84
Div. Directional Score 4.48 --
Next Divdend (Est)
(2024-06-07)
$0 Estimate 0.00 %
Dividend Stability
0.05 Very Bad
Dividend Score
3.06
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2005 $0.500 3.07%
2006 $0.500 2.01%
2007 $2.00 9.47%
2008 $1.500 11.20%
2009 $0.645 6.68%
2010 $1.280 8.72%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
VGI Dividend Royal 2024-02-09 Monthly 13 7.36% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.01901.500-0.379-0.569[0 - 0.5]
returnOnAssetsTTM-0.006071.200-0.202-0.243[0 - 0.3]
returnOnEquityTTM0.1711.5009.2110.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.3010.8008.506.80[1 - 3]
quickRatioTTM0.6850.800-0.679-0.543[0.8 - 2.5]
cashRatioTTM0.2201.5009.8910.00[0.2 - 2]
debtRatioTTM0.819-1.50010.00-10.00[0 - 0.6]
interestCoverageTTM-0.7251.000-1.380-1.380[3 - 30]
operatingCashFlowPerShareTTM3.002.009.0010.00[0 - 30]
freeCashFlowPerShareTTM2.232.008.8910.00[0 - 20]
debtEquityRatioTTM-21.91-1.500-10.0010.00[0 - 2.5]
grossProfitMarginTTM0.9951.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.1101.0009.809.80[0.1 - 0.6]
cashFlowToDebtRatioTTM0.04891.000-0.839-0.839[0.2 - 2]
assetTurnoverTTM0.3200.800-1.199-0.959[0.5 - 2]
Total Score6.11

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-19.161.000-2.040[1 - 100]
returnOnEquityTTM0.1712.509.4910.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.232.009.2610.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM3.002.009.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.3901.500-5.930[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1251.0009.370[0.1 - 0.5]
Total Score2.84

Bausch Health Companies

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.